Dr Asif Ahmed has taken to TikTok to alert patients to the long term side effects - including addiction - of using three ...

Dr Asif Ahmed took to TikTok to issue a warning about three particular forms of medication, which he claims can prove ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

Gabapentinoids are increasingly prescribed as an alternative to pain medicines for nursing home residents, but the reasoning behind the prescriptions — and beliefs about efficacy and deprescribing — ...

Millions of Americans suffer from undiagnosed pain, often stemming from joint issues or neuropathy. NexGenEsis Healthcare is at the forefront of helping these individuals heal through cutting-edge ...

Nonoperative treatment, such physical therapy, is the typical approach to treating rotator-cuff tears. However, surgery is considered in certain patients whose rotator-cuff tears don't resolve with ...

Brian T. Feeley, MD, FAAOS, was bestowed with the 2025 Kappa Delta Elizabeth Winston Lanier Award for his research in ...

Shoulder symptoms led to an average of 9.6 million physician visits in 2015 and 2016 in the United States.The most common cause of those shoulder ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.